San Francisco-based health technology startup Nurx will deliver Truvada to the homes of residents who qualify. (Courtesy Nurx)

San Francisco-based health technology startup Nurx will deliver Truvada to the homes of residents who qualify. (Courtesy Nurx)

SF startup will ship preventative HIV medication to your doorstep

HIV prevention medication delivered right to your door? There’s an app for that.

San Francisco-based health technology startup Nurx announced last week that it will deliver Truvada, a medication that helps prevent transmission of HIV, to the homes of high risk individuals who qualify for the service.

The online delivery app is available for California residents and is meant for people who are considered to be at high-risk of contracting the virus. That includes men who engage in sex with other men and couples in which one partner is HIV positive and the other is not, according to Nurx.

Taken once a day, Truvada is said to be up to 99 percent effective in preventing transmission of the virus, according to Edvard Engesaeth, a medical doctor and the cofounder of Nurx. Truvada was first approved by the Food and Drug Administration in 2012 and has since been used to combat new transmissions of HIV in the U.S. The preventative method is also known as pre-exposure prophylaxis.

“By making (Truvada) more accessible to high-risk users, the Nurx app has the potential to be a game-changer in the fight to end an epidemic,” Hans Gangeskar, CEO and founder of the company, said in a statement.

The online delivery service is among numerous efforts to reduce the often deadly effects of HIV. Last year, the San Francisco Department of Public Health reported 371 new HIV infections in The City, the lowest figure since the epidemic first began back in the 1980s, as previously reported by the San Francisco Examiner.

In 2014, Supervisor Scott Wiener revealed that he takes Truvada in an effort to raise awareness about the HIV-prevention tool.

To qualify for the delivery service, high risk individuals must fill out an online application, which is sent to a physician to determine the patient’s eligibility for Truvada. Lab testing for HIV, pregnancy and sexually transmitted diseases is also required to qualify, according to Nurx.

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

The City has struggled to conduct outreach in some neighborhoods as it works to expand Slow Streets — such as this section of Page Street in the Lower Haight — to underserved neighborhoods. <ins>(Jordi Molina/Special to S.F. Examiner)</ins>
SFMTA delays vote on Bayview Slow Streets, approves five others in ‘underserved’ areas

SFMTA struggles to conduct outreach in neighborhoods with lower internet access

Stern Grove Festival organizers are planning to bring back the popular summer concert series — The Isley Brothers show in 2019 is pictured — with limited audience capacity. (Ming Vong/S.F. Examiner)
Indoor shows won’t be flooding SF stages soon but Stern Grove might be back in June

While San Francisco Mayor London Breed announced that live performances may resume… Continue reading

San Francisco Giants pitcher Johnny Cueto  (47) started on Opening Day against the Colorado Rockies at Oracle Park on April 9, 2021. (Photography by Chris Victorio | Special to the S.F. Examiner).
Giants welcome fans back with strong performance by Cueto

By Ethan Kassel Special to S.F. Examiner ORACLE PARK — The first… Continue reading

James Harbor appears in court after he was arrested on charges in the July 4th shooting death of 6-year-old Jace Young on Friday, Jan. 8, 2021. (Kevin N. Hume/S.F. Examiner)
Murder case heads to trial over killing of 6-year-old Jace Young

Hearing reveals new details in ‘horrific’ Fourth of July shooting

BART passengers may see more frequent service by this fall. (Kevin N. Hume/S.F. Examiner)
BART service increases possible as soon as September

Proposal would double weekday, daytime trains and extend system operating hours

Most Read